Michael Tarzi

1.2k total citations
17 papers, 563 citations indexed

About

Michael Tarzi is a scholar working on Immunology and Allergy, Physiology and Immunology. According to data from OpenAlex, Michael Tarzi has authored 17 papers receiving a total of 563 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Immunology and Allergy, 5 papers in Physiology and 5 papers in Immunology. Recurrent topics in Michael Tarzi's work include Food Allergy and Anaphylaxis Research (6 papers), Allergic Rhinitis and Sensitization (6 papers) and Asthma and respiratory diseases (5 papers). Michael Tarzi is often cited by papers focused on Food Allergy and Anaphylaxis Research (6 papers), Allergic Rhinitis and Sensitization (6 papers) and Asthma and respiratory diseases (5 papers). Michael Tarzi collaborates with scholars based in United Kingdom, United States and Croatia. Michael Tarzi's co-authors include Mark Larché, Hilary Longhurst, A B Kay, Clare Alexander, Tamás Forster, Catherine Texier, Bernard Maillère, Adrienne Verhoef, Steven O. Stapel and Cezmi A. Akdiş and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Allergy and Clinical Immunology and Allergy.

In The Last Decade

Michael Tarzi

17 papers receiving 538 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Tarzi United Kingdom 12 201 197 159 142 80 17 563
Alejandro Malbrán Argentina 14 76 0.4× 332 1.7× 58 0.4× 234 1.6× 169 2.1× 58 653
Kamruz Darabi United States 8 80 0.4× 447 2.3× 47 0.3× 148 1.0× 31 0.4× 13 749
C. Wang United States 6 184 0.9× 145 0.7× 70 0.4× 35 0.2× 183 2.3× 15 536
Kathleen M. David-Bajar United States 15 92 0.5× 174 0.9× 43 0.3× 76 0.5× 297 3.7× 20 564
Anna Tosi Italy 12 78 0.4× 142 0.7× 58 0.4× 33 0.2× 16 0.2× 42 478
M. Vogelbruch Germany 7 75 0.4× 76 0.4× 72 0.5× 35 0.2× 46 0.6× 10 381
Jean-Marie Saint-Remy Belgium 16 158 0.8× 203 1.0× 94 0.6× 141 1.0× 28 0.3× 46 993
Laura Maximiliane Ehmann Germany 6 73 0.4× 150 0.8× 32 0.2× 16 0.1× 35 0.4× 16 431
K Kasahara Japan 12 75 0.4× 200 1.0× 97 0.6× 26 0.2× 9 0.1× 22 400
Anna Peroni Italy 12 58 0.3× 80 0.4× 30 0.2× 37 0.3× 160 2.0× 16 501

Countries citing papers authored by Michael Tarzi

Since Specialization
Citations

This map shows the geographic impact of Michael Tarzi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Tarzi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Tarzi more than expected).

Fields of papers citing papers by Michael Tarzi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Tarzi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Tarzi. The network helps show where Michael Tarzi may publish in the future.

Co-authorship network of co-authors of Michael Tarzi

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Tarzi. A scholar is included among the top collaborators of Michael Tarzi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Tarzi. Michael Tarzi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Lansley, Alison B., Marcus Allen, Lucas D. Bowler, et al.. (2021). Stability testing of the Pfizer-BioNTech BNT162b2 COVID-19 vaccine: a translational study in UK vaccination centres. SHILAP Revista de lepidopterología. 5(1). e100203–e100203. 22 indexed citations
2.
Anderson, Nina K., et al.. (2016). Recognizing and managing food-dependent exercise-induced anaphylaxis. British Journal of Hospital Medicine. 77(3). 190–191. 1 indexed citations
3.
Longhurst, Hilary, Michael Tarzi, Claire Bethune, et al.. (2015). C1 inhibitor deficiency: 2014 United Kingdom consensus document. Clinical & Experimental Immunology. 180(3). 475–483. 23 indexed citations
4.
Read, N. W., et al.. (2014). Paediatric hereditary angioedema: a survey of UK service provision and patient experience. Clinical & Experimental Immunology. 178(3). 483–488. 17 indexed citations
6.
Beltran, Luisa, Michael J. Koenig, William Egner, et al.. (2013). High-titre circulating tissue transglutaminase-2 antibodies predict small bowel villous atrophy, but decision cut-off limits must be locally validated. Clinical & Experimental Immunology. 176(2). 190–198. 41 indexed citations
7.
Smith, Karen, Nicola J. Gray, Elizabeth Cheek, et al.. (2013). Characterisation of CD154+ T cells following ex vivo birch allergen stimulation defines a close relationship between T cell subsets in healthy volunteers. BMC Immunology. 14(1). 7 indexed citations
8.
Smith, Karen, et al.. (2011). Pollen-food syndrome is related to Bet v 1/PR-10 protein sensitisation, but not all patients have spring rhinitis. Allergy. 66(10). 1391–1392. 17 indexed citations
9.
Yong, Patrick, Michael Tarzi, Ignatius Chua, Bodo Grimbacher, & Ronnie Chee. (2008). Common Variable Immunodeficiency: An Update on Etiology and Management. Immunology and Allergy Clinics of North America. 28(2). 367–386. 48 indexed citations
10.
Tarzi, Michael, Sofia Grigoriadou, S.B. Carr, L.M. Kuitert, & Hilary Longhurst. (2008). Clinical Immunology Review Series: An approach to the management of pulmonary disease in primary antibody deficiency. Clinical & Experimental Immunology. 155(2). 147–155. 37 indexed citations
11.
Tarzi, Michael, et al.. (2007). An evaluation of tests used for the diagnosis and monitoring of C1 inhibitor deficiency: normal serum C4 does not exclude hereditary angio-oedema. Clinical & Experimental Immunology. 149(3). 513–516. 80 indexed citations
12.
Khan, Sujoy, et al.. (2006). Secondary systemic lupus erythematosus: An analysis of 4 cases of uncontrolled hereditary angioedema. Clinical Immunology. 123(1). 14–17. 21 indexed citations
13.
Tarzi, Michael, Sven Klunker, Catherine Texier, et al.. (2006). Induction of interleukin‐10 and suppressor of cytokine signalling‐3 gene expression following peptide immunotherapy. Clinical & Experimental Allergy. 36(4). 465–474. 111 indexed citations
14.
Alexander, Clare, Michael Tarzi, Mark Larché, & A B Kay. (2005). The effect of Fel d 1‐derived T‐cell peptides on upper and lower airway outcome measurements in cat‐allergic subjects. Allergy. 60(10). 1269–1274. 96 indexed citations
15.
Tarzi, Michael, et al.. (2005). Sporadic case of warts, hypogammaglobulinemia, immunodeficiency, and myelokathexis syndrome. Journal of Allergy and Clinical Immunology. 116(5). 1101–1105. 27 indexed citations
16.
Tarzi, Michael & Mark Larché. (2003). Peptide immunotherapy for allergic disease. Expert Opinion on Biological Therapy. 3(4). 617–626. 9 indexed citations
17.
Tarzi, Michael, Catherine Texier, Bernard Maillère, Mark Larché, & A B Kay. (2003). Effect of HLA-DR-based T cell peptides derived from phospholipase A2 on late-phase skin reactions and T cell function in subjects with mild honeybee allergy. Journal of Allergy and Clinical Immunology. 111(2). S198–S198. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026